Results 321 to 330 of about 3,028,209 (373)

Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition). [PDF]

open access: yesFront Pharmacol
Zhao B   +28 more
europepmc   +1 more source

Public Interest in the Off-Label Use of Glucagon-Like Peptide 1 Agonists (Ozempic) for Cosmetic Weight Loss: A Google Trends Analysis.

Aesthetic surgery journal, 2023
BACKGROUND Glucagon-like peptide 1 (GLP-1) agonists are a drug class used for the treatment of diabetes that have recently gained FDA approval for medical management of obesity.
Sabrina H Han   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy